drugset
drugset / Trial / NCT04867317

Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)

NCT04867317 ↗

Phase 3 Recruiting 172 enrolled VA Office of Research and Development
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether growth hormone replacement therapy (GHRT) is effective versus placebo in the improvement of Quality of Life in patients with adult growth hormone deficiency (AGHD) and mild traumatic brain injury (mTBI).

Timeline

Start
2025-01-13
Primary completion
2027-02-28
Completion
2029-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Somatropin Protein / enzyme biologic — —

Indications

non-acquired pituitary hormone deficiency traumatic brain injury